The recommendations for use of consistent language will significantly improve patient awareness and understanding of potentially life-saving testing options available for both new cancer diagnoses and progression or recurrence of disease.
COVID-19 has produced far-reaching and significant health impacts, including a drastic reduction in all cancer screenings. In response, national nonprofit Colorectal Cancer Alliance and the National Colorectal Cancer Roundtable—an organization founded by the American Cancer Society and the Centers for Disease Control and Prevention—convened a panel of prevention and screening experts to offer a united response and propose national guidance on improving colorectal cancer screening rates during the COVID-19 era.
The Colorectal Cancer Alliance (Alliance) launches its Personalized Biomarker Patient Education Campaign to empower patients and caregivers with information about how precision treatment planning in colorectal cancer through biomarker testing can help improve survival
The Never Too Young Survey Report shares the self-reported medical, psychosocial, and quality of life experiences of this often-overlooked population to better understand their challenges and needs.
In January 2019, Brooks Bell was diagnosed with stage-III colon cancer at age 38. She underwent six months of surgeries and chemotherapy. During that time, she learned of the shocking rise of colorectal cancer in young people, which inspired her to share her story, establish an awareness campaign, and start an initiative and event to encourage colorectal cancer screening.
The Colorectal Cancer Alliance and the National Colorectal Cancer Roundtable convened a panel of prevention and screening experts to offer a united response and propose national guidance on improving colorectal cancer screening rates during the COVID-19 era.
The March Forth Leadership Council brings together expertise and resources from a variety of stakeholders to improve colorectal cancer screening in targeted communities.
The Colorectal Cancer Alliance announced its Walk to End Colon Cancer—a fundraising event series that empowers a nation of allies to walk together and raise money to screen, care, and cure this disease.
Colorectal Cancer Alliance CEO Michael Sapienza will discuss the importance of colorectal cancer screening with Congressman Donald M. Payne, Jr. and Kathleen Sebelius, former United States Secretary of Health and Human Services, on March 11 in Washington, D.C.
The Colorectal Cancer Alliance revealed its digital awareness campaign "Tomorrow Can’t Wait," an approachable campaign that visually illustrates what is on the line for individuals to get screened (your bottom) and all ages can be affected.
The Sacramento Undy, which includes a 5K and one-mile fun run, raises funds to end the third leading cause of cancer-related deaths in the United States among men and women combined, while honoring those affected by it.
The Tampa Bay Undy RunWalk, which includes a 5K and one-mile fun run, raises funds to end the third leading cause of cancer-related deaths in the United States among men and women combined, while honoring those affected by it.
The Colorectal Cancer Alliance has announced available funding for up to $1.1 million for innovative, life-saving research through its Chris4Life Research Program. Research proposals are being accepted here through Monday, March 16, 2020.
National non-profit the Colorectal Cancer Alliance hosted their 9th Annual Blue Hope Bash on Saturday, November 2, at the Andrew W. Mellon Auditorium in Washington, D.C.
The Washington region’s most generous allies will join together for an evening in blue to raise funds to end colorectal cancer in our lifetime, when the Colorectal Cancer Alliance hosts its annual Blue Hope Bash gala on Saturday, November 2.
In memory of Kiess, 94 golfers raised more than $50,000 in one afternoon. The money will support the Alliance’s life-saving efforts to screen, care, and cure colorectal cancer.
Colorectal cancer is a ride no one wants to take, but knowing the symptoms and getting screened can prevent America’s second-deadliest cancer and save lives.
The Colorectal Cancer Alliance today announced it will fund research led by Dr. Megan Hitchens of Cedars-Sinai Medical Center in Los Angeles to determine if blood-based tests for methylated circulating tumor DNA will accurately detect colorectal cancer in people under age 50.
The Board of Directors of the Colorectal Cancer Alliance voted June 21 to appoint Scott Wilson to a three-year term, effective immediately. Wilson is a young-onset colorectal cancer survivor and business leader who presently heads corporate affairs at Molson Coors Brewing Company.
National nonprofit Colorectal Cancer Alliance is calling on allies to participate in its fourth annual survey of young-onset colorectal cancer patients, survivors, and caregivers. The survey lets the Alliance learn about and track the self-reported medical, psychosocial, and quality of life experiences of allies.
